Hovan Ramps Up Market Neutral Fund Team

Feb 6 2008 | 9:44am ET

Hovan Capital Management, a San Francisco-based healthcare focused long/short fund, has hired Ajim Tamboli as a senior portfolio manager of the HCM Market Neutral Fund. Tamboli previously served as a senior small biotechnology analyst at Lehman Brothers in San Francisco.

In addition, Lisa Lee-Hwong, previously with SAC Capital Advisors, has joined the firm to support Tamboli as a portfolio manager focused on emerging science. Current HCM analyst Mikael van Loon will be promoted to the role of portfolio manager in charge of top-down quantitative portfolio risk management.

“Ajim’s experience and interaction with the management teams of portfolio companies coupled with Dr. Lee-Hwong’s scientific research experience will provide a strong positive environment in HCM’s public equity healthcare research department,” said Kurt Hovan, president and CIO of HCM.

“Mikael has mastered HCM’s short portfolio quantitative process and is ready to assume the role of portfolio manager in the fund.”

Hovan Capital Management was established in September 1998.


In Depth

PAAMCO: Will Inflation Deflate the Asset Bubble?

Jan 30 2018 | 9:49pm ET

As the U.S. shifts from monetary stimulus to fiscal stimulus, market pricing should...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Boost Hedge Fund Marketing ROI By Raising Your ROO

Feb 14 2018 | 9:57pm ET

Tasked with delivering returns on client capital, a common dilemma for many alternative...

 

FINalternatives Trending

From the current issue of